Indian Supreme Court Rejects Novartis Appeal; Upholds High Standard for Section 3(d)

[Press Release from the Lawyers Collective (Contact)]  In a triumphant victory for patients fighting for access to medicines, a division bench of the Supreme Court of India comprising Hon’ble Justice Aftab Alam and Hon’ble Justice Ranjana Desai, today dismissed Swiss MNC Novartis’ appeal for a patent to Novartis for its anti-cancer medicine, imatinib mesylate (Gleevec). [...]